Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic TransplantationAbraham S. Kanate, Mehdi Hamadani, Kwang Woo Ahn et al.|Transplantation and Cellular Therapy|2017Cited by 11
Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)Mehdi Hamadani, Abraham S. Kanate, Marcelo C. Pasquini et al.|Transplantation and Cellular Therapy|2016Cited by 1